However, one industry observer cautions against moving forward with specific GLP-1 claims on packaging until federal agencies ...

Novo has been trying to strengthen its foothold in the potential $150 billion obesity market through the development of ...

Here is Danone North America’s commercial masterstroke laid bare: the food, beverage and nutrition company manages to promote ...

However, one industry observer cautions against moving forward with specific GLP-1 claims on packaging until federal agencies ...

Biomea Fusion (BMEA) announced the presentation of preclinical and clinical data from studies assessing icovamenib at the Advanced Technologies ...

The Artisan International Small-Mid Fund portfolio outperformed the MSCI ACWI ex USA SMID Index in Q4 of 2024. Click here to ...

A pharmacist has shared the possible pain-relieving benefits of the type 2 diabetes drug Mounjaro, which could help millions ...

Eli Lilly’s Mounjaro has launched in India. Approved by CDSCO, it promises significant weight loss and blood sugar control. However, concerns remain over certain side effects.

Eli Lilly launches Mounjaro, the much-awaited diabetes drug, in India. It is priced at ₹3,500 for 2.5 mg. Mounjaro and ...

Hims & Hers is shifting towards personalized medicine with AI-backed solutions. Find out why HIMS stock is buyable despite ...

GLP-1 RA use is associated with better graft and patient survival among kidney transplant recipients with diabetes.